Full Press Release Details
Issues Financial Guidance for 2009 and Updates Guidance for 2008
Dublin, Ireland--(BUSINESS WIRE)--January 9, 2009--ICON (NASDAQ: ICLR),
a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries, today
announced financial guidance for 2009.
2009 net revenue is expected to be in the range of $930 - $980 million.
This compares to an expected outcome of $862 - $865 million for the year
ended December 31, 2008, a reduction on previous guidance due to
2009 net income per diluted share is expected to be in the range of
$1.40 - $1.52. This compares to $1.27 - $1.29 for the year ended
December 31, 2008, an increase on previous guidance.
The company will hold a conference call today, January 9th,
at 09:00 EST [14:00 Ireland & UK]. A question and answer session will
The statements made in this Press Release may contain forward-looking
statements that involve a number of risks and uncertainties. In addition
to the matters described in this Press Release, the ability to maintain
large client contracts or enter into new contracts, maintain client
relationships and the ability to manage the opening of new offices, the
integration of new business mergers and acquisitions, as well as other
risks and uncertainties detailed from time to time in SEC reports filed
by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the
actual results achieved by ICON. ICON disclaims any intent or obligation
to update these forward-looking statements.
ICON plc is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The Company
specializes in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. ICON teams have successfully conducted over
5,500 development projects and consultancy engagements across all major
therapeutic areas. ICON currently has over 6,800 employees, operating
from 71 locations in 38 countries.
Further information is available at www.iconplc.com.
Investor Relations 1-888-381-7923 or
Murray CFO + 353 -1-291-2000